HOXB13 and prostate carcinoma: For example, a targeted sequencing study of a cohort of 5,083 prostate cancer patients has shown that 1.4% of prostate cancer patients have a recurrent G84E mutation in HOXB13, which increases in prevalence to 3.1% among early-onset prostate cancer patients with family history of the disease (42).